Claims Implying Supplement Could Replace Insulin Must Go, NAD Says
This article was originally published in The Tan Sheet
Implying that eFoodSafety.com's glucose-metabolism supplement Cinnergen is a replacement for normal insulin regimens is misleading, the National Advertising Division says
You may also be interested in...
Vital Pharmaceuticals must modify advertising for its Redline Princess women's energy drink because there is no evidence the product would "enhance mood, energy and fat loss," according to the National Advertising Division
The National Advertising Division refers eFoodSafety.com to the Federal Trade Commission for possible law enforcement action for Internet advertising claims the firm made about its Cinnergen dietary supplement. As part of its routine monitoring program, NAD targeted Cinnergen for health-related establishment and performance claims including: "clinically proven to control blood sugar" and "over half the patients in our clinical study were able to stop taking prescribed medication!" according to a Feb. 7 decision. The Council of Better Business Bureaus group's numerous attempts to contact eFoodSafety were unsuccessful, NAD says...
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement